Stockscreener 앱 받기
4.53
3.82%
-0.18
전일 마감가:
$4.71
열려 있는:
$4.71
하루 거래량:
6,499
Relative Volume:
0.04
시가총액:
$7.03M
수익:
$8.62M
순이익/손실:
$-6.15M
주가수익비율:
-0.4107
EPS:
-11.03
순현금흐름:
$-5.32M
1주 성능:
-6.60%
1개월 성능:
-12.55%
6개월 성능:
+110.70%
1년 성능:
-11.87%
1일 변동 폭
$4.511
$4.74
1주일 범위
$4.3904
$4.87
52주 변동 폭
$1.94
$12.32
Evoke Pharma Inc Stock (EVOK) Company Profile
명칭
Evoke Pharma Inc
전화
858-345-1494
주소
420 STEVENS AVENUE, SOLANA BEACH, CA
EVOK을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
EVOK
Evoke Pharma Inc
|
4.511 | 7.36M | 8.62M | -6.15M | -5.32M | -11.03 |
|
ZTS
Zoetis Inc
|
143.50 | 63.58B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.90 | 43.58B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.195 | 40.83B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
19.68 | 23.07B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
431.03 | 19.61B | 3.08B | 1.24B | 1.07B | 25.61 |
Evoke Pharma Inc Stock (EVOK) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2020-06-22 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2019-03-05 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2018-03-08 | 재확인 | B. Riley FBR, Inc. | Buy |
| 2017-10-19 | 재개 | FBR & Co. | Buy |
| 2017-03-16 | 재확인 | Rodman & Renshaw | Buy |
| 2017-01-30 | 업그레이드 | Laidlaw | Neutral → Buy |
| 2017-01-05 | 업그레이드 | Rodman & Renshaw | Neutral → Buy |
| 2016-12-23 | 재확인 | Rodman & Renshaw | Neutral |
| 2016-07-19 | 재확인 | FBR Capital | Outperform |
| 2016-07-19 | 다운그레이드 | Noble Financial | Buy → Hold |
| 2016-07-18 | 다운그레이드 | Rodman & Renshaw | Buy → Neutral |
| 2016-03-16 | 개시 | Northland Capital | Outperform |
| 2016-03-14 | 재확인 | Ascendiant Capital Markets | Buy |
| 2016-02-17 | 재개 | FBR Capital | Outperform |
| 2014-12-03 | 재확인 | MLV & Co | Buy |
| 2014-11-07 | 개시 | MLV & Co | Buy |
| 2014-04-22 | 개시 | Laidlaw | Buy |
| 2013-11-19 | 개시 | Aegis Capital | Buy |
모두보기
Evoke Pharma Inc 주식(EVOK)의 최신 뉴스
How currency fluctuations impact Evoke Pharma Inc. stockRate Hike & Technical Confirmation Trade Alerts - newser.com
Evoke Pharma Inc.’s volatility index tracking explainedEarnings Beat & Risk Controlled Stock Alerts - newser.com
Will Evoke Pharma Inc. stock return to pre crisis levelsTrade Analysis Summary & Daily Profit Maximizing Tips - newser.com
What valuation multiples suggest for Evoke Pharma Inc. stockJuly 2025 Reactions & High Yield Stock Recommendations - newser.com
Does Evoke Pharma Inc. fit your quant trading modelGlobal Markets & Technical Buy Zone Confirmations - newser.com
Real time alert setup for Evoke Pharma Inc. performanceDay Trade & Free Community Consensus Stock Picks - newser.com
Using data tools to time your Evoke Pharma Inc. exitMarket Trend Report & Consistent Income Trade Ideas - newser.com
Short interest data insights for Evoke Pharma Inc.Dollar Strength & Real-Time Market Trend Scan - newser.com
What to expect from Evoke Pharma Inc. in the next 30 daysDay Trade & Daily Profit Maximizing Tips - newser.com
Weiss Ratings Reiterates “Sell (E+)” Rating for Evoke Pharma (NASDAQ:EVOK) - Defense World
Will Evoke Pharma Inc. stock recover after recent drop2025 Price Action Summary & Verified Momentum Stock Ideas - newser.com
Sector ETF performance correlation with Evoke Pharma Inc.Trade Entry Report & Verified Entry Point Signals - newser.com
Institutional scanner results for Evoke Pharma Inc.Breakout Watch & Verified High Yield Trade Plans - newser.com
How to monitor Evoke Pharma Inc. with trend dashboardsRecession Risk & Safe Capital Investment Plans - newser.com
What Fibonacci levels say about Evoke Pharma Inc. rebound2025 Market Overview & Growth Focused Investment Plans - newser.com
Is Evoke Pharma Inc a good long term investmentLarge Cap Stability Picks & Register for the Next Free Workshop - earlytimes.in
News impact scoring models applied to Evoke Pharma Inc.2025 Market Trends & Technical Confirmation Trade Alerts - newser.com
Evoke Pharma Inc (EVOK) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.68%
0.65%
자본화:
|
볼륨(24시간):